Atlas Trials

Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC

Clinical trial NCT07403435 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07403435
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2026-02-15
Primary completion
2027-05-31
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.